About Exin Therapeutics
Exin Therapeutics is a private company based in San Francisco, California, incorporated in 2024 in Delaware. It has reported $2,162,300 raised in one offering on Form D since February 2026. Its chief executive is Gabriel Ocana Santero.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 18, 2024 | Feb 10, 2026 | $2,162,300fully sold | 28 | $77,225 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Exin Therapeutics's Form D filed Feb 10, 2026.
GS
Gabriel Ocana Santero
Chief Executive Officer and director
IL
Ivan Alex Priela Lazarte
Executive officer and director
MT
Marko Tvrdic
Executive officer and director